Carl O’Connell is the founder of Catalyst OrthoScience. Catalyst OrthoScience has raised $20M in total funding. Latest round: Series A.
Carl O'Connell is the President and CEO of Catalyst OrthoScience, a medical technology company focused on shoulder arthroplasty. He has held this role since January 2022, during which the company surpassed 10,000 total shoulder arthroplasty procedures and secured $20 million in financing.
Full founder directory · Investor directory · Company funding database · Fundraising library